FrancophonIA/ELRC3.0 huggingface dataset:
English: In diabetic hypertensive patients with microalbuminuria and normal renal function, hyperkalaemia (≥ 5.5 mEq/L) occurred in 29.4% of the patients in the irbesartan 300 mg group and 22% of the patients in the placebo group.
Danish: Hos diabetiske, hypertensive patienter med mikroalbuminuri og normal nyrefunktion sås hyperkalæmi (≥5,5 mEq/l) hos 29,4% af patienterne i irbesartan 300 mg-gruppen og 22% af patienterne i placebogruppen.
English: 14 tablets 28 tablets 56 tablets 56 x 1 tablets 84 tablets 98 tablets
Danish: 14 tabletter 28 tabletter 56 tabletter 56 x 1 tabletter 84 tabletter 98 tabletter
English: Because no information is available regarding the use of Irbesartan BMS during breast-feeding, Irbesartan BMS is not recommended and alternative treatments with better established safety profiles during breast-feeding are preferable, especially while nursing a newborn or preterm infant.
Danish: Da der ikke foreligger oplysninger om anvendelse af Irbesartan BMS under amning, frarådes brugen af Irbesartan BMS, og andre behandlingsregimer med en mere veletableret sikkerhedsprofil for anvendelse under amning bør foretrækkes.
English: Uncommon: heart rate increased, flushing, cough, diarrhoea, indigestion/heartburn, sexual dysfunction (problems with sexual performance), chest pain.
Danish: Ikke almindeligt: hurtig hjerterytme, rødme, hoste, diarré, fordøjelsesbesvær/halsbrand, seksuelle problemer, brystsmerter.
English: NAME OF THE MARKETING AUTHORISATION HOLDER BRISTOL-MYERS SQUIBB PHARMA EEIG
Danish: NAVN PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN BRISTOL-MYERS SQUIBB PHARMA EEIG
English: Irbesartan BMS slows the decrease of kidney function in patients with high blood pressure and type 2 diabetes.
Danish: Irbesartan BMS mindsker faldende nyrefunktionen hos patienter med forhøjet blodtryk og type 2diabetes.
English: What Irbesartan BMS is and what it is used for Before you take Irbesartan BMS How to take Irbesartan BMS Possible side effects
Danish: Irbesartan BMSs virkning og hvad du skal bruge det til Det skal du vide, før du begynder at bruge Irbesartan BMS
English: Irbesartan BMS is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).
Danish: Irbesartan BMS bør ikke bruges tidligt i graviditeten og du må ikke tage Irbesartan BMS, hvis du er længere end 3 måneder henne i din graviditet, da det kan skade dit barn alvorligt, hvis det bruges i den periode (se afsnittet om graviditet).
English: Hyperkalaemia: as with other medicinal products that affect the renin-angiotensin-aldosterone system, hyperkalaemia may occur during the treatment with Irbesartan BMS, especially in the presence of renal impairment, overt proteinuria due to diabetic renal disease, and/or heart failure.
Danish: Hyperkaliæmi: Som med andre lægemidler, der påvirker renin-angiotensin-aldosteron systemet, kan der opstå hyperkaliæmi under behandling med Irbesartan BMS, specielt i tilfælde af nyrefunktionsnedsættelse, klinisk proteinuri på grund af diabetisk nyresygdom, og/eller hjertefejl.
English: Patients should be adequately hydrated and consideration should be given to monitoring renal function after initiation of concomitant therapy, and periodically thereafter.
Danish: Der bør overvejes at monitorere nyrefunktionen eftersamtidig behandling er initieret og periodisk derefter.
English: Lactose monohydrate Hypromellose Titanium dioxide Macrogol 3000
Danish: Hypromellose Titandioxid (E171) Macrogol 3000
English: Hypertension and type 2 diabetes with renal disease The “Irbesartan Diabetic Nephropathy Trial (IDNT)” shows that irbesartan decreases the progression of renal disease in patients with chronic renal insufficiency and overt proteinuria.
Danish: Hypertensive patienter med type 2 diabetisk nyresygdom IDNT studiet (Irbesartan Diabetic Nephropathy Trial) har vist, at irbesartan nedsætter progression af nyresygdom hos patienter med kronisk nyre insufficiens og klinisk proteinuri.
English: In this case your doctor may perform regular blood tests, especially for measuring blood potassium levels in case of poor kidney function if you are going to have an operation (surgery) or be given anaesthetics You must tell your doctor if you think you are (or might become) pregnant.
Danish: I dette tilfælde kan lægen tage regelmæssige blodprøver med særlig henblik på at måle kaliumniveauet i blodet, hvis nyrefunktionen er nedsat hvis du skal opereres eller bedøves.
English: The other ingredients are microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, colloidal hydrated silica, pregelatinised maize starch, and poloxamer 188.
Danish: Øvrige indholdsstoffer: lactosemonohydrat, mikrokrystallinsk cellulose, croscarmellosenatrium, magnesiumstearat, kolloid silica, prægelatineret majsstivelse, poloaxamer 188.
English: In diabetic hypertensive patients with chronic renal insufficiency and overt proteinuria, hyperkalaemia (≥ 5.5 mEq/L) occurred in 46.3% of the patients in the irbesartan group and 26.3% of the patients in the placebo group.
Danish: Blandt diabetiske, hypertensive patienter med kronisk nyreinsufficiens og udtalt proteinuri sås hyperkalæmi (≥5,5 mEq/l) hos 46,3% af patienterne i irbesartangruppen og 26,3% af patienterne i placebogruppen.
English: C irbesartan, about 20% of the radioactivity is recovered in the urine, and the remainder in the faeces.
Danish: Efter enten oral eller intravenøs administration af 14C irbesartan, genfindes ca. 20% radioaktivitet i urinen og resten i afføringen.
English: In 1,715 hypertensive patients with type 2 diabetes, proteinuria ≥ 900 mg/day and serum creatinine ranging from 1.0-3.0 mg/dl, the long-term effects (mean 2.6 years) of Irbesartan BMS on the progression of renal disease and all-cause mortality were examined.
Danish: Hos 1.715 hypertensive patienter med type 2-diabetes, proteinuri ≥ 900 mg/dag og serumkreatininværdier i intervallet 1,0-3,0 mg/dl, evalueredes langtidseffekterne (median 2,6 år) ved Irbesartan BMS med henblik på progression af nyresygdom og totalmortalitet.
English: Animal studies with irbesartan showed transient toxic effects (increased renal pelvic cavitation, hydroureter or subcutaneous oedema) in rat foetuses, which were resolved after birth.
Danish: I Dyrestudier med irbesartan sås forbigående toksisk effekt (øget nyrebækken kavitation, hydroureter eller subkutant ødem) hos rottefostre.
English: The demonstration of renal benefit of Irbesartan BMS in hypertensive type 2 diabetic patients is based on studies where irbesartan was used in addition to other antihypertensive agents, as needed, to reach target blood pressure (see section 5.1).
Danish: Dokumentationen for forbedring af nyresygdom ved brug af Irbesartan BMS hos hypertensive type 2-diabetikere er baseret på studier, hvor irbesartan blev brugt efter behov med tillæg af andre antihypertensive lægemidler, for at nå det ønskede blodtryk (se pkt.
English: Irbesartan BMS is not recommended in early pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
Danish: Du bør ikke tage Irbesartan BMS i begyndelsen af graviditeten, og du må ikke tage det, hvis du er længere end 3 måneder henne i din graviditet, da det kan skade dit barn alvorligt, hvis du tager det efter tredje måned af graviditeten.
English: Irbesartan BMS is used to treat high blood pressure (essential hypertension) to protect the kidney in patients with high blood pressure, type 2 diabetes and laboratory evidence of impaired kidney function.
Danish: Irbesartan BMS anvendes til at behandle forhøjet blodtryk (hypertension) til at beskytte nyrerne hos patienter med for højt blodtryk, type 2-diabetes og blodprøver, der
English: Respiratory, thoracic and mediastinal disorders: Uncommon: cough
Danish: Luftveje, thorax og mediastinum: Ualmindelig:
English: The other ingredients are lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, hypromellose, silicon dioxide, magnesium stearate, titanium dioxide, macrogol 3000, carnauba wax.
Danish: Øvrige indholdsstoffer: lactosemonohydrat, mikrokrystallinsk cellulose, croscarmellosenatrium, hypromellose, silicondioxid, magnesiumstearat, titandioxid (E171), macrogol 3000,
English: Potassium supplements and potassium-sparing diuretics: based on experience with the use of other medicinal products that affect the renin-angiotensin system, concomitant use of potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium or other medicinal products that may increase serum potassium levels (e.g. heparin) may lead to increases in serum potassium and is, therefore, not recommended (see section 4.4).
Danish: Kaliumtilskud og kalium-besparende diuretika: Erfaringer med brug af andre lægemidler, der indvirker på renin-angiotensin systemet, viser at samtidig brug af kalium-besparende diuretika, kaliumtilskud, kaliumholdige salterstatninger eller andre lægemidler, som kan øge serumkaliumniveauet (fx heparin), kan medføre øget serum-kalium, Derfor frarådes samtidig brug med sådanne lægemidler (se pkt.
English: Renal impairment and kidney transplantation: when Irbesartan BMS is used in patients with impaired renal function, a periodic monitoring of potassium and creatinine serum levels is recommended.
Danish: Nyrefunktionsnedsættelse og nyretransplantation: Der anbefales periodisk kontrol af serum-kalium- og serum-kreatinin, hvis Irbesartan BMS anvendes til patienter med nedsat nyrefunktion.
English: LIST OF EXCIPIENTS Excipients: also contains lactose monohydrate.
Danish: Indholdsstoffer: indeholder også lactosemonohydrat.
English: Each tablet of Irbesartan BMS 75 mg contains 75 mg irbesartan.
Danish: Hver Irbesartan BMS-tablet 75 mg indeholder 75 mg irbesartan.
English: Irbesartan BMS does not usually interact with other medicines.
Danish: Almindeligvis påvirker eller påvirkes Irbesartan BMS ikke af anden medicin.
English: Reproductive system and breast disorders: Uncommon: sexual dysfunction
Danish: Det reproduktive system og mammae: Ualmindelig:
English: Hypertensive patients with type 2 diabetes and renal disease: the effects of irbesartan both on renal and cardiovascular events were not uniform across all subgroups, in an analysis carried out in the study with patients with advanced renal disease.
Danish: Hypertensive patienter med type 2 diabetes og nefropati: I en undersøgelse med patienter med fremskreden nyresygdom var effekten af irbesartan på nyrer og kardiovaskulære hændelser ikke den sammei alle sub-grupper.
English: Each tablet of Irbesartan BMS 300 mg contains 300 mg irbesartan.
Danish: Hver Irbesartan BMS-tablet 300 mg indeholder 300 mg irbesartan.
English: INFORMATION IN BRAILLE Irbesartan BMS 75 mg
Danish: INFORMATION I BRAILLE-SKRIFT Irbesartan BMS 75 mg
English: As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk of worsening of renal function, including possible acute renal failure, and an increase in serum potassium, especially in patients with poor pre-existing renal function.
Danish: Som det er tilfældet med ACE-hæmmere, kan samtidig anvendelse af antiotensin II- antagonister og NSAID medføre øget risiko for forværring af nyrefunktionen, herunder muligt akut nyresvigt samt øgning af serum-kalium.
English: Each tablet of Irbesartan BMS 150 mg contains 150 mg irbesartan.
Danish: Hver Irbesartan BMS-tablet 150 mg indeholder 150 mg irbesartan.
English: INFORMATION IN BRAILLE Irbesartan BMS 300 mg
Danish: INFORMATION I BRAILLE-SKRIFT Irbesartan BMS 300 mg
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains: irbesartan 75 mg
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver tablet indeholder: irbesartan 75 mg
English: Irbesartan BMS is for oral use.
Danish: Irbesartan BMS skal tages gennem munden.
English: In patients with high blood pressure and type 2 diabetes with kidney disease, dizziness when getting up from a lying or sitting position, low blood pressure when getting up from a lying or sitting position, pain in joints or muscles and decreased levels of a protein in the red blood cells (haemoglobin) were also reported.
Danish: Almindeligt: svimmelhed, kvalme/opkastning, træthed og blodprøver, der viser en forhøjet mængde af et enzym, der måler muskel- og hjertefunktionen (kreatinin-kinase-enzym).Der er hos patienter med forhøjet blodtryk og type 2-diabetes med nyresygdom også indberettet svimmelhed, når man rejser sig op fra liggende eller siddende stilling, lavt blodtryk når man rejser sig op fra liggende eller siddende stilling, led- og muskelsmerter og en nedsat mængde protein i de røde blodlegemer (hæmoglobin).
English: INFORMATION IN BRAILLE Irbesartan BMS 150 mg
Danish: INFORMATION I BRAILLE-SKRIFT Irbesartan BMS 150 mg
English: Cartons of 56 x 1 film-coated tablet; 7 blister cards of 8 x 1 film-coated tablet each in PVC/PVDC/Aluminium perforated unit dose blisters.
Danish: Æsker med 56 x 1 filmovertrukne tabletter; 7 blisterkort med 8 x 1 filmovertrukken tablet i hvert perforeret PVC/PVDC/aluminiumblister med éngangsdoser.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains: irbesartan 150 mg
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver tablet indeholder: irbesartan 150 mg
English: MARKETING AUTHORISATION NUMBERS EU/1/06/375/028-033
Danish: MARKEDSFØRINGSTILLADELSESNUMRE EU/1/06/375/028-033
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains: irbesartan 300 mg
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver tablet indeholder: irbesartan 300 mg
English: Diuretics and other antihypertensive agents: other antihypertensive agents may increase the hypotensive effects of irbesartan; however Irbesartan BMS has been safely administered with other antihypertensive agents, such as beta-blockers, long-acting calcium channel blockers, and thiazide diuretics.
Danish: På trods af dette er Irbesartan BMS uden risiko blevet administreret sammen med andre antihypertensive lægemidler som beta-blokkere, langtidsvirkende calciumantagonister samt diuretika af thiazidtypen.
English: MARKETING AUTHORISATION NUMBERS EU/1/06/375/016-021
Danish: MARKEDSFØRINGSTILLADELSESNUMRE EU/1/06/375/016-021
English: MARKETING AUTHORISATION NUMBERS EU/1/06/375/022-027
Danish: MARKEDSFØRINGSTILLADELSESNUMRE EU/1/06/375/022-027
English: Always take Irbesartan BMS exactly as your doctor has told you.
Danish: SÅDAN SKAL DU BRUGE IRBESARTAN BMS Tag altid Irbesartan BMS nøjagtigt efter lægens anvisning.
English: Musculoskeletal and connective tissue disorders: Common:
Danish: Knogler, led, muskler og bindevæv : Almindelig:
English: OTHER
Danish: On
English: Renal impairment: no dosage adjustment is necessary in patients with impaired renal function.
Danish: Nyrefunktionsnedsættelse: Det er ikke nødvendigt at dosisjustere patienter med nedsat nyrefunktion.
English: NAME OF THE MEDICINAL PRODUCT Irbesartan BMS 75 mg tablets.
Danish: LÆGEMIDLETS NAVN Irbesartan BMS 75 mg tabletter.
English: Excipient: 61.50 mg of lactose monohydrate per tablet.
Danish: Hjælpestof: 61,50 mg lactosemonohydrat per tablet.
English: NAME OF THE MEDICINAL PRODUCT Irbesartan BMS 75 mg tablets irbesartan
Danish: LÆGEMIDLETS NAVN Irbesartan BMS 75 mg tabletter irbesartan
English: NAME OF THE MEDICINAL PRODUCT Irbesartan BMS 150 mg tablets.
Danish: LÆGEMIDLETS NAVN Irbesartan BMS 150 mg tabletter.
English: Excipient: 15.37 mg of lactose monohydrate per tablet.
Danish: Hjælpestof: 15,37 mg lactosemonohydrat per tablet.
English: NAME OF THE MEDICINAL PRODUCT Irbesartan BMS 300 mg tablets.
Danish: LÆGEMIDLETS NAVN Irbesartan BMS 300 mg tabletter.
English: Excipient: 30.75 mg of lactose monohydrate per tablet.
Danish: Hjælpestof: 30,75 mg lactosemonohydrat per tablet.
English: PACKAGE LEAFLET: INFORMATION FOR THE USER Irbesartan BMS 75 mg tablets irbesartan
Danish: INDLÆGSSEDDEL: INFORMATION TIL BRUGEREN Irbesartan BMS 75 mg tabletter irbesartan
English: (18 - 40 years).
Danish: 4.3 og 4.4).
English: NAME OF THE MEDICINAL PRODUCT Irbesartan BMS 300 mg tablets irbesartan
Danish: LÆGEMIDLETS NAVN Irbesartan BMS 300 mg tabletter irbesartan
English: PACKAGE LEAFLET: INFORMATION FOR THE USER Irbesartan BMS 300 mg tablets irbesartan
Danish: INDLÆGSSEDDEL: INFORMATION TIL BRUGEREN Irbesartan BMS 300 mg tabletter irbesartan
English: NAME OF THE MEDICINAL PRODUCT Irbesartan BMS 150 mg tablets irbesartan
Danish: LÆGEMIDLETS NAVN Irbesartan BMS 150 mg tabletter irbesartan
English: NAME OF THE MEDICINAL PRODUCT Irbesartan BMS 75 mg film-coated tablets.
Danish: LÆGEMIDLETS NAVN Irbesartan BMS 75 mg filmovertrukne tabletter.
English: PACKAGE LEAFLET: INFORMATION FOR THE USER Irbesartan BMS 150 mg tablets irbesartan
Danish: INDLÆGSSEDDEL: INFORMATION TIL BRUGEREN Irbesartan BMS 150 mg tabletter irbesartan
English: Cartons of 14 tablets: 1 blister card of 14 tablets in PVC/PVDC/Aluminium blisters.
Danish: Æsker med 14 tabletter: 1 blisterkort med 14 tabletter i PVC/PVDC/aluminiumblistere.
English: NAME OF THE MEDICINAL PRODUCT Irbesartan BMS 75 mg film-coated tablets irbesartan
Danish: LÆGEMIDLETS NAVN Irbesartan BMS 75 mg filmovertrukne tabletter irbesartan
English: PACKAGE LEAFLET: INFORMATION FOR THE USER Irbesartan BMS 75 mg film-coated tablets irbesartan
Danish: INDLÆGSSEDDEL: INFORMATION TIL BRUGEREN Irbesartan BMS 75 mg filmovertrukne tabletter irbesartan
English: In 1.7% of hypertensive patients with advanced diabetic renal disease treated with irbesartan, a decrease in haemoglobin*, which was not clinically significant, has been
Danish: Der er set fald i hæmoglobin, som ikke var klinisk signifikant, hos 1,7% (dvs almindelig) af de hypertensive patienter med fremskreden diabetisk nyresygdom
English: Irbesartan BMS 75 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Danish: Irbesartan BMS 75 mg tabletter leveres i blisterpakninger á 14, 28, 56 eller 98 tabletter.
English: Irbesartan BMS 300 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Danish: Irbesartan BMS 300 mg tabletter leveres i blisterpakninger á 14, 28, 56 eller 98 tabletter.
English: BEFORE YOU TAKE IRBESARTAN BMS
Danish: DET SKAL DU VIDE, FØR DU BEGYNDER AT BRUGE IRBESARTAN BMS
English: Cartons of 56 tablets: 4 blister cards of 14 tablets in PVC/PVDC/Aluminium blisters.
Danish: Æsker med 56 tabletter: 4 blisterkort med 14 tabletter i PVC/PVDC/aluminiumblistere.
English: Cartons of 28 tablets: 2 blister cards of 14 tablets in PVC/PVDC/Aluminium blisters.
Danish: Æsker med 28 tabletter: 2 blisterkort med 14 tabletter i PVC/PVDC/aluminiumblistere.
English: NAME OF THE MEDICINAL PRODUCT Irbesartan BMS 150 mg film-coated tablets.
Danish: LÆGEMIDLETS NAVN Irbesartan BMS 150 mg filmovertrukne tabletter.
English: Irbesartan BMS 150 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Danish: Irbesartan BMS 150 mg tabletter leveres i blisterpakninger á 14, 28, 56 eller 98 tabletter.
English: Cartons of 98 tablets: 7 blister cards of 14 tablets in PVC/PVDC/Aluminium blisters.
Danish: Æsker med 98 tabletter: 7 blisterkort med 14 tabletter i PVC/PVDC/aluminiumblistere.
English: Cartons of 84 film-coated tablets: 6 blister cards of 14 film-coated tablets in PVC/PVDC/Aluminium blisters.
Danish: Æsker med 84 filmovertrukne tabletter: 6 blisterkort med 14 filmovertrukne tabletter i PVC/PVDC/aluminiumblistere.
English: NAME OF THE MEDICINAL PRODUCT Irbesartan BMS 300 mg film-coated tablets.
Danish: LÆGEMIDLETS NAVN Irbesartan BMS 300 mg filmovertrukne tabletter.
English: Cartons of 14 film-coated tablets: 1 blister card of 14 film-coated tablets in PVC/PVDC/Aluminium blisters.
Danish: Æsker med 14 filmovertrukne tabletter: 1 blisterkort med 14 filmovertrukne tabletter i PVC/PVDC/aluminiumblistere.
English: Excipient: 102.00 mg of lactose monohydrate per film-coated tablet.
Danish: Hjælpestof: 102,00 mg lactosemonohydrat per tablet.
English: Excipient: 25.50 mg of lactose monohydrate per film-coated tablet.
Danish: Hjælpestof: 25,50 mg lactosemonohydrat per tablet.
English: Cartons of 28 film-coated tablets: 2 blister cards of 14 film-coated tablets in PVC/PVDC/Aluminium blisters.
Danish: Æsker med 28 filmovertrukne tabletter: 2 blisterkort med 14 filmovertrukne tabletter i PVC/PVDC/aluminiumblistere.
English: Cartons of 56 film-coated tablets: 4 blister cards of 14 film-coated tablets in PVC/PVDC/Aluminium blisters.
Danish: Æsker med 56 filmovertrukne tabletter: 4 blisterkort med 14 filmovertrukne tabletter i PVC/PVDC/aluminiumblistere.
English: PACKAGE LEAFLET: INFORMATION FOR THE USER Irbesartan BMS 150 mg film-coated tablets irbesartan
Danish: INDLÆGSSEDDEL: INFORMATION TIL BRUGEREN Irbesartan BMS 150 mg filmovertrukne tabletter irbesartan
English: Cartons of 98 film-coated tablets: 7 blister cards of 14 film-coated tablets in PVC/PVDC/Aluminium blisters.
Danish: Æsker med 98 filmovertrukne tabletter: 7 blisterkort med 14 filmovertrukne tabletter i PVC/PVDC/aluminiumblistere.
English: Irbesartan BMS 150 mg film-coated tablets are supplied in blister packs of 14, 28, 56, 84 or 98 filmcoated tablets.
Danish: Irbesartan BMS 150 mg filmovertrukne tabletter leveres i blisterpakninger á 14, 28, 56, 84 eller 98 filmovertrukne tabletter.
English: Do not pass it on to others.
Danish: Lad derfor være med at give Irbesartan BMS til andre.
English: Irbesartan BMS 300 mg film-coated tablets are supplied in blister packs of 14, 28, 56, 84 or 98 filmcoated tablets.
Danish: Irbesartan BMS 300 mg filmovertrukne tabletter leveres i blisterpakninger á 14, 28, 56, 84 eller 98 filmovertrukne tabletter.
English: NAME OF THE MEDICINAL PRODUCT Irbesartan BMS 150 mg film-coated tablets irbesartan
Danish: LÆGEMIDLETS NAVN Irbesartan BMS 150 mg filmovertrukne tabletter irbesartan
English: NAME OF THE MEDICINAL PRODUCT Irbesartan BMS 300 mg film-coated tablets irbesartan
Danish: LÆGEMIDLETS NAVN Irbesartan BMS 300 mg filmovertrukne tabletter irbesartan
English: What Irbesartan BMS looks like and contents of the pack Irbesartan BMS 75 mg tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2771 engraved on the other side.
Danish: Irbesartan BMSs udseende og pakningstørrelse Irbesartan BMS 75 mg tabletter er hvide til mathvide, bikonvekse og ovale med et hjerte præget på den ene side og nummeret 2771 på den anden side.
English: PACKAGE LEAFLET: INFORMATION FOR THE USER Irbesartan BMS 300 mg film-coated tablets irbesartan
Danish: INDLÆGSSEDDEL: INFORMATION TIL BRUGEREN Irbesartan BMS 300 mg filmovertrukne tabletter irbesartan
English: Irbesartan BMS 75 mg film-coated tablets are supplied in blister packs of 14, 28, 56, 84 or 98 filmcoated tablets.
Danish: Irbesartan BMS 75 mg filmovertrukne tabletter leveres i blisterpakninger á 14, 28, 56, 84 eller 98 filmovertrukne tabletter.
English: THE MARKETING AUTHORISATION HOLDER Medicinal product subject to medical prescription
Danish: B. BETINGELSER FOR MARKEDSFØRINGSTILLADELSEN BETINGELSER ELLER BEGRÆNSNINGER PÅLAGT INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN VEDRØRENDE UDLEVERING OG BRUG Lægemidlet må kun udleveres efter recept.
English: EU/1/06/375/011 - 14 tablets EU/1/06/375/012 - 28 tablets EU/1/06/375/013 - 56 tablets EU/1/06/375/014 - 56 x 1 tablets EU/1/06/375/015 - 98 tablets
Danish: EU/1/06/375/011 - 14 tabletter EU/1/06/375/012 - 28 tabletter EU/1/06/375/013 - 56 tabletter EU/1/06/375/014 - 56 x 1 tabletter EU/1/06/375/015 - 98 tabletter
English: What Irbesartan BMS looks like and contents of the pack Irbesartan BMS 300 mg film-coated tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2873 engraved on the other side.
Danish: Irbesartan BMSs udseende og pakningstørrelse Irbesartan BMS 300 mg filmovertrukne tabletter er hvide til mathvide, bikonvekse og ovale med et hjerte præget på den ene side og nummeret 2873 på den anden side.